Emerging role of Rituximab in adult minimal change disease: a narrative review of clinical evidence, biomarkers and future perspectives

Ricong Xu(Shenzhen Second People's Hospital), Yu Yi(Xuzhou Medical College), Qijun Wan(Shenzhen Second People's Hospital), Tao Cao(Shenzhen Second People's Hospital)
BMC Nephrology
March 26, 2025
10.1186/s12882-025-04086-3
Cited by 5

Related Papers

Neutrophil Percentage-to-Albumin Ratio and Risk of Mortality in Patients on Peritoneal Dialysis
|Journal of Inflammation Research|2023|46
Homocysteine and Arterial Occlusive Diseases
|Advances in Cardiovascular Diseases|2003|11
P2.04-54 Characteristic of MSI-H Lung Cancer Patients Identified with Targeted Next-Generation Sequencing
|Journal of Thoracic Oncology|2019|4
Label-Free Monitoring of Endometrial Cancer Progression Using Multiphoton Microscopy
|Annals of Biomedical Engineering|2024|4
Different Dosage Regimens of Rituximab in Primary Membranous Nephropathy Treatment: A Systematic Review
|International Journal of Nephrology and Renovascular Disease|2024|4